PeptideDB

Talatisamine

CAS No.: 20501-56-8

1. Talatisamine (12 μM) and TEA (5mM) inhibits the enhanced I(K) caused by Aβ4 oligomers, attenuates cytotoxicity of A
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description 1. Talatisamine (12 μM) and TEA (5mM) inhibits the enhanced I(K) caused by Aβ4 oligomers, attenuates cytotoxicity of Aβ oligomers by restoring cell viability and suppressing K(+) loss related apoptotic response. 2. Talatisamine can therefore be considered as a leading compound worthy of further investigations.
Target activity IK channel:146 μM
Synonyms 塔拉乌头胺, 塔拉萨敏
molecular weight 421.57
Molecular formula C24H39NO5
CAS 20501-56-8
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 32 mg/mL(75.9 mM) Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble
References 1. Song M K , Liu H , Jiang H L , et al. Discovery of talatisamine as a novel specific blocker for the delayed rectifier K+ channels in rat hippocampal neurons.[J]. Neuroscience, 2008, 155(2):469-475.